2405-5255

Osteoporosis and Sarcopenia

Elsevier

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 717 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact717 DOIs
2

Attach ORCID iDs across 452 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact452 DOIs
3

Deposit reference lists for 373 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact373 DOIs

DOIs for this ISSN

Showing the top 5 of 717 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Locomotive syndrome in Japan (10.1016/j.afos.2018.09.004)
Abstract ORCID
102.65 112
2 The effect of glucocorticoids on bone and muscle (10.1016/j.afos.2015.07.008)
Abstract ORCID
100.00 99
3 Diabetes and bone (10.1016/j.afos.2019.05.001)
Abstract ORCID
94.32 76
4 The role of sex steroid hormones in the pathophysiology and… (10.1016/j.afos.2016.06.002)
Abstract ORCID
90.31 63
5 The correlation between bone mineral density/trabecular bone… (10.1016/j.afos.2017.02.001)
Abstract ORCID
85.80 51
6 Osteoporosis prevention and osteoporosis exercise in communi… (10.1016/j.afos.2016.11.004)
Abstract ORCID
83.14 45
7 Molecular mechanisms and therapeutic interventions in sarcop… (10.1016/j.afos.2017.08.098)
Abstract ORCID
83.14 45
8 The prevalence of sarcopenia and related factors in a commun… (10.1016/j.afos.2016.05.001)
Abstract ORCID
82.17 43
9 Lean mass and peak bone mineral density (10.1016/j.afos.2020.10.001)
Abstract ORCID
80.10 39
10 Individualized fracture risk assessment: State-of-the-art an… (10.1016/j.afos.2018.03.001)
Abstract ORCID
78.41 36
11 Locomotive syndrome presents a risk for falls and fractures… (10.1016/j.afos.2016.06.001)
Abstract ORCID
77.82 35
12 Sarcopenia in Asia (10.1016/j.afos.2015.10.001)
Abstract ORCID
76.57 33
13 School-based exercise interventions effectively increase bon… (10.1016/j.afos.2018.05.002)
Abstract ORCID
73.86 29
14 Effect of alendronate on muscle mass: Investigation in patie… (10.1016/j.afos.2015.07.005)
Abstract ORCID
70.75 25
15 Recent advances in vitamin K-dependent Gla-containing protei… (10.1016/j.afos.2015.07.009)
Abstract ORCID
69.90 24
16 Recent nutritional trends of calcium and vitamin D in East A… (10.1016/j.afos.2016.08.002)
Abstract ORCID
69.90 24
17 Bone regeneration with umbilical cord blood mesenchymal stem… (10.1016/j.afos.2018.08.003)
Abstract ORCID
69.01 23
18 Review on the comparison of effectiveness between denosumab… (10.1016/j.afos.2016.03.003)
Abstract ORCID
68.09 22
19 Fracture liaison services improve outcomes of patients with… (10.1016/j.afos.2017.08.096)
Abstract References ORCID
67.73 7
20 Risk factors and epidemiological profile of hip fractures in… (10.1016/j.afos.2017.08.097)
Abstract ORCID
63.94 18
21 Sarcopenia affects conservative treatment of osteoporotic ve… (10.1016/j.afos.2018.09.002)
Abstract ORCID
63.94 18
22 Sarcopenia and lower limb pain are additively related to mot… (10.1016/j.afos.2019.03.002)
Abstract ORCID
62.76 17
23 An updated hip fracture projection in Asia: The Asian Federa… (10.1016/j.afos.2018.03.003)
Abstract
62.14 305
24 Antiosteoporotic activity of Salvadora persica sticks extrac… (10.1016/j.afos.2017.07.002)
Abstract ORCID
60.21 15
25 Is osteoporosis a risk factor for ankle fracture?: Compariso… (10.1016/j.afos.2017.11.005)
Abstract ORCID
60.21 15
26 Bone turnover rate and bone formation/resorption balance dur… (10.1016/j.afos.2016.12.001)
Abstract ORCID
58.80 14
27 Associations between serum 25-hydroxyvitamin D 3 level and s… (10.1016/j.afos.2017.02.002)
Abstract ORCID
58.80 14
28 Osteoporosis knowledge assessment and osteoporosis education… (10.1016/j.afos.2016.03.001)
Abstract ORCID
57.31 13
29 Clinical aspects and management of osteoporosis and fragilit… (10.1016/j.afos.2017.08.101)
Abstract ORCID
57.31 13
30 Surgical treatment of severe osteoporosis including new conc… (10.1016/j.afos.2017.11.006)
Abstract ORCID
57.31 13
31 Diagnosis of knee osteoarthritis and gait variability increa… (10.1016/j.afos.2015.07.003)
Abstract ORCID
55.70 12
32 New treatments of osteoporosis (10.1016/j.afos.2015.07.007)
Abstract ORCID
55.70 12
33 The Asian Federation of Osteoporosis Societies' call to acti… (10.1016/j.afos.2017.11.002)
Abstract ORCID
55.70 12
34 Association of obesity and sarcopenia among adult Filipinos (10.1016/j.afos.2018.08.001)
Abstract ORCID
55.70 12
35 One-year mortality rate after osteoporotic hip fractures and… (10.1016/j.afos.2015.07.006)
Abstract ORCID
53.96 11
36 Medical treatment of severe osteoporosis including new conce… (10.1016/j.afos.2016.02.003)
Abstract ORCID
52.07 10
37 Bidirectional ephrin signaling in bone (10.1016/j.afos.2016.05.002)
Abstract ORCID
52.07 10
38 Aluminum toxicity to bone: A multisystem effect? (10.1016/j.afos.2019.01.001)
Abstract
50.84 107
39 Sarcopenia and mortality in cancer: A meta-analysis (10.1016/j.afos.2021.03.002)
Abstract
50.63 105
40 A summary of the Malaysian Clinical Guidance on the manageme… (10.1016/j.afos.2016.02.004)
Abstract ORCID
50.00 9
41 Effects of combined therapy of alendronate and low-intensity… (10.1016/j.afos.2017.11.001)
Abstract ORCID
47.71 8
42 Sarcopenia in elderly patients with chronic low back pain (10.1016/j.afos.2017.09.001)
Abstract
46.88 74
43 Sarcopenia and mortality in different clinical conditions: A… (10.1016/j.afos.2021.02.001)
Abstract
46.28 70
44 Romosozumab for the treatment of osteoporosis (10.1016/j.afos.2018.03.002)
Abstract
46.13 69
45 Higher free thyroxine levels are associated with sarcopenia… (10.1016/j.afos.2015.11.001)
Abstract ORCID
45.15 7
46 The effects of sarcopenia and obesity on femur neck bone min… (10.1016/j.afos.2016.04.002)
Abstract ORCID
45.15 7
47 Favorable effects of skeletal muscle on bone are distinguish… (10.1016/j.afos.2016.11.001)
Abstract ORCID
45.15 7
48 Overcoming osteoporosis and beyond: Locomotive syndrome or d… (10.1016/j.afos.2018.09.001)
Abstract ORCID
45.15 7
49 Serotonin reuptake inhibitors and bone health: A review of c… (10.1016/j.afos.2017.05.002)
Abstract
44.63 60
50 South Asian Working Action Group on SARCOpenia (SWAG-SARCO)… (10.1016/j.afos.2022.04.001)
Abstract
44.45 59